Barry J. Simon

CIK 1647994 · See remarks · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$20.08M

Companies

4

Total Filings

36

Lifetime Open-Market Net

-$17.32M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IBRX Director 2,827,788 $7.10 $20.08M -$5.96M 13 2026-06-05
Viracta Therapeutics, Inc. (VIRX) Delisted Director $0.01 $0 4 2024-06-24
ImmunityBio, Inc. (NK) Delisted See remarks 3,213,783 -$11.36M 15 2021-02-08
CUE Director $24.53 $0 4 2021-01-06

Recent Filings · Page 4 of 4

36 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-01-03 CUE Grant (A) $0 EDGAR
2018-08-29 ImmunityBio, Inc. (NK) Delisted Grant (A) $0 EDGAR
2018-06-14 CUE Exer (M) $0 EDGAR
2016-09-09 ImmunityBio, Inc. (NK) Delisted Sell (S) −32,000 -$239.7K EDGAR
2016-07-28 ImmunityBio, Inc. (NK) Delisted Mixed +105,828 -$546.5K EDGAR
2015-08-05 ImmunityBio, Inc. (NK) Delisted Mixed +88,538 -$2.42M EDGAR
Showing 3136 of 36
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.